Mental Health

Do you have Clinical Depression that is Treatment Resistant?

For our patient who are suffering from depression despite two or more antidepression medications, VCare is providing an FDA approved therapy. This new approach is both safe and effective. The medication Spravato (esketamine) works in a novel way. Unlike the standard therapy that aims to increase certain chemicals in the brain (neurotransmitters, Spravato repairs nerve structure and efficiency.

Spravato (Mental Health) has a unique mechanism of action, targeting the N-methyl-D-aspartate (NMDA) receptor. It’s typically administered under medical supervision, and its effects are thought to help regulate mood and alleviate symptoms of depression.

One of the notable aspects of Spravato is its mechanism of action, as it works differently from traditional antidepressants. It is thought to modulate glutamate, a neurotransmitter in the brain associated with learning and memory. The rapid onset of action observed with esketamine has been a subject of interest in the field of psychiatry.

This therapy is focused on revitalizing nerve cells and their networks degraded by stress, and depression. This is known as promoting neuroplasticity. Call and speak to one of our medical professionals to see if Spravato is right for you.